The global advanced wound care market size is expected to reach USD 16.85 Billion in 2030 and register a revenue CAGR of 6.7% over the forecast period, according to latest report. Increasing prevalence of diabetes and pressure ulcers is expected to be one of the major drivers for advanced wound care market growth. For instance, as per National Institute of Diabetes and Digestive Kidney Diseases (NIDDK), around 30 million people in the U.S. have diabetes, with 1.5 million new diagnoses each year. Moreover, according to a study published in BioMed Research International, the prevalence of diabetes was about 5.4%, 4.2%, 3.3%, 6.8%, and 7.7% in 2001, 2003, 2005, 2007-2008, and 2009-2010 respectively in U.S., which has been continuously increasing with time.
The advanced wound care market comprises of product types such as hydrogels, alginates, collagen dressings, hydrocolloids, film dressings, and others. Among these, the alginates segment is anticipated to grow at the highest CAGR over the forecast period. This can be attributed to its wide range of applications in various types of wounds including partial- and full-thickness wounds, pressure ulcers, venous stasis ulcers, diabetic foot ulcers, and burns.
The major factors driving the growth of the market are rising incidence of acute diseases and trauma cases. According to National Institutes of Health, in 2017, there were 29.1 million visits to emergency departments for injuries in the United States.
According to the Wound Care Society, around 6.5 million people in the United Kingdom suffer from chronic wounds. Furthermore, according to the National Center for Biotechnology Information, in 2015, around 25% of people aged above 60 years have at least one chronic wound. Moreover, increasing number of surgical procedures and growing geriatric population are also expected to support the growth of the market. However, reimbursement issues related to advanced wound care products and high cost of treatment are anticipated to restraint the market growth during the forecast period.
Increasing prevalence of chronic diseases, such as diabetic venous leg ulcers, pressure ulcers, and arterial ulcers, is one of the major factors projected to boost the demand for advanced wound care products during the forecast period. In addition, rising geriatric population and increasing number of surgical procedures are other major factors projected to fuel the growth of this market during the forecast period.
The advanced wound care market comprises of product types such as hydrogels, alginates, collagen dressings, hydrocolloids, film dressings, and others. Among these, the alginates segment is anticipated to grow at the highest CAGR over the forecast period. This can be attributed to its wide range of applications in various types of wounds including partial- and full-thickness wounds, pressure ulcers, venous stasis ulcers, diabetic foot ulcers, and burns.
The major factors driving the growth of the market are rising incidence of acute diseases and trauma cases. According to National Institutes of Health, in 2017, there were 29.1 million visits to emergency departments for injuries in the United States.
According to the Wound Care Society, around 6.5 million people in the United Kingdom suffer from chronic wounds. Furthermore, according to the National Center for Biotechnology Information, in 2015, around 25% of people aged above 60 years have at least one chronic wound. Moreover, increasing number of surgical procedures and growing geriatric population are also expected to support the growth of the market. However, reimbursement issues related to advanced wound care products and high cost of treatment are anticipated to restraint the market growth during the forecast period.
Increasing prevalence of chronic diseases, such as diabetic venous leg ulcers, pressure ulcers, and arterial ulcers, is one of the major factors projected to boost the demand for advanced wound care products during the forecast period. In addition, rising geriatric population and increasing number of surgical procedures are other major factors projected to fuel the growth of this market during the forecast period.
Some Key Highlights from the Report
- In March 2020, Smith+Nephew, the global medical technology company, launched PICO 7 Single Use Negative Pressure Wound Therapy System, which is a portable and easy-to-use system that helps in the management of chronic or acute wounds.
- The infection management segment held a significant revenue share in the advanced wound care market in 2021, and this trend is expected to continue during the forecast period. This can be ascribed to the increasing number of surgical site infections (SSIs). According to an article published by the National Institutes of Health (NIH) in 2015, SSIs are among the most common complications associated with surgeries. The incidence of SSIs is especially high in lower-risk procedures, such as hernia repair and knee replacement.
- As per the findings of a study published in The Lancet Infectious Diseases in 2016, the global SSI rate was 4.6% in 2012. Moreover, the Centers for Disease Control and Prevention (CDC) estimates that SSIs account for 20% of all hospital-acquired infections in the U.S.
- The rising number of surgical site infections is expected to drive the demand for advanced wound care products, such as antimicrobial dressings and negative pressure wound therapy (NPWT) devices, over the forecast period.
- Chronic wounds are persistent injuries that take a significant amount of time to heal. The global advanced wound care market is primarily driven by the rising prevalence of chronic wounds, which has been increasing at a rapid pace over the last decade. According to a study published in 2016 by the Wound Care Society, nearly 6.5 million people suffer from chronic wounds in the U.S., which is expected to increase to 7.2 million by 2025.
- The rising prevalence of diabetes is another major factor driving the growth of the advanced wound care market. Diabetes is one of the leading causes of chronic wounds, as it can lead to diabetic foot ulcers (DFUs). According to the American Diabetes Association, nearly 30.3 million people in the U.S. suffer from diabetes, which is expected to increase to 34.2 million by 2040.
- The rising geriatric population is another major factor driving the growth of the advanced wound care market. The geriatric population is more susceptible to chronic wounds, as they have a weakened immune system and often suffer from underlying health conditions, such as diabetes and arterial insufficiency. According to the World Health Organization, the global geriatric population is expected to reach 2.1 billion by 2050.
- The global advanced wound care market is segmented into four major geographies, namely, North America, Europe, Asia-Pacific (APAC), and Rest of the World. The APAC region includes countries such as China, Japan, India, South Korea, and Australia.
- North America is expected to grow at the highest CAGR during the forecast period. The large share of this region can be attributed to the high incidence of diabetes and other chronic wounds, the growing geriatric population, and the increasing prevalence of obesity.
For this report, the publisher has segmented the global advanced wound care market based on product, wound type, end-use, and region:
Product Outlook (Revenue, USD Billion; 2019-2030)
- Infection Management
- Silver Wound Dressings
- Non-silver Wound Dressings
- Collagen Dressings
- Exudate Management
- Hydrocolloids Dressings
- Foam Dressings
- Alginate Dressings
- Hydrogel Dressings
- Active Wound Care
- Skin Substitutes
- Growth Factors
- Devices and Accessories
- NPWT Devices and Accessories
- Debridement Devices and Accessories
- Wound Assessment and Monitoring Devices
- Other Devices and Accessories
- Grafts and Matrices
- Topical Agents
Wound Type Outlook (Revenue, USD Billion; 2019-2030)
- Acute Wounds
- Burns and Traumatic Wounds
- Surgical Wounds
- Chronic Wounds
- Diabetic Foot Ulcers
- Pressure Ulcers
- Venous Legs Ulcers
- Other Wounds
End-use Outlook (Revenue, USD Billion; 2019-2030)
- Hospitals
- Wound Care Centers
- Homecare Settings
- Others
Regional Outlook (Revenue, USD Billion; 2019-2030)
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- U.K.
- France
- Italy
- Spain
- Sweden
- BENELUX
- Rest of Europe
- Asia-Pacific
- China
- India
- Japan
- South Korea
- Rest of APAC
- Latin America
- Brazil
- Rest of LATAM
- Middle East & Africa
- Saudi Arabia
- UAE
- South Africa
- Israel
- Rest of MEA
Table of Contents
Chapter 1. Market Synopsis
Chapter 2. Executive Summary
Chapter 4. Advanced Wound Care Market Segmentation & Impact Analysis
Chapter 5. Advanced Wound Care Market By Product Insights & Trends
Chapter 6. Advanced Wound Care Market By Wound Type Insights & Trends
Chapter 7. Advanced Wound Care Market By End-use Insights & Trends
Chapter 8. Advanced Wound Care Market Regional Outlook
Chapter 9. Competitive Landscape
Chapter 10. Company Profiles
Companies Mentioned
- 3M
- Smith+Nephew
- ConvaTec Group PLC
- Coloplast Group
- Molnlycke Health Care AB
- Paul Hartmann AG
- B. Braun Melsungen AG
- Organogenesis Inc.
- Medtronic
- DermaRite Industries LLC
